Filing Details
- Accession Number:
- 0000059478-15-000225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-10 14:09:12
- Reporting Period:
- 2015-12-09
- Filing Date:
- 2015-12-10
- Accepted Time:
- 2015-12-10 14:09:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1476151 | A Enrique Conterno | Lilly Corporate Center Indianapolis IN 46285 | Sr. Vp & Pres., Lilly Diabetes | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-12-09 | 25,000 | $83.88 | 88,131 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,792 | Indirect | 401(k) |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $83.66 to $84.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.